| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |